Islamabad: Pakistan’s battle against antimicrobial resistance (AMR) is extending beyond hospitals to poultry farms, food supplies and wastewater, where misuse of antibiotics is helping drug-resistant bacteria emerge and threatening medicines needed to treat life-threatening infections, experts warned on Wednesday.
Citing a study published in The Lancet Microbe, they said Pakistan imported nearly 702 tonnes of colistin as animal feed additives between 2017 and 2020, despite the antibiotic being regarded as a critical treatment option for certain multidrug-resistant infections in humans.
The findings have renewed concerns over antibiotic use in the country, where an estimated 39,700 deaths were directly attributable to bacterial antimicrobial resistance in 2021, while resistant infections were associated with approximately 161,000 deaths, according to international disease-burden estimates, they added.
Infectious diseases experts expressed these concerns during an awareness seminar organised by the Department of Infectious Diseases at the Pakistan Institute of Medical Sciences (PIMS), Islamabad, at the MCH auditorium on Wednesday, marking the beginning of World Antimicrobial Resistance Awareness Week, observed from November 18 to 24.
The international campaign is being held under the theme “One Health, one action: Prevent AMR now.” An awareness walk was also organised inside PIMS to sensitise healthcare professionals and the public about the growing threat.
Prof Dr Naseem Akhtar, head of the Infectious Diseases Department at PIMS, emphasised the importance of rational antibiotic prescribing, laboratory-supported treatment and effective infection-control practices.
She called for greater public awareness about self-medication and unnecessary antibiotic consumption, alongside stronger coordination among healthcare professionals to preserve existing medicines.
One Health and biosecurity specialist Muhammad Farooq Tahir said research in Faisalabad detected the colistin-resistance gene mcr-1 in 17 percent of commercial broilers, 13 percent of chicken meat samples and seven percent of sewage samples. Three of 200 hospital patients also carried the gene, although the findings did not establish how resistance spread.
He said colistin, often reserved for difficult hospital infections, had been used in poultry for disease prevention and growth promotion. In a small survey, all 18 farmers and drug sellers interviewed reported preventive use and access without veterinary prescriptions, highlighting regulatory weaknesses.
Farooq Tahir called for stronger veterinary prescribing controls, coordinated surveillance and closer communication between doctors, veterinarians and food-safety authorities. Animal-health resistance surveillance had expanded from five to nine sites, but information was not adequately shared between sectors.
Consultant microbiologist Dr Asima Niazi said Pakistan’s outbreak of extensively drug-resistant typhoid, first detected in Hyderabad in 2016, demonstrated the importance of laboratory testing. By August 2019, more than 10,000 XDR typhoid cases had been reported across 23 districts of Sindh.
She said blood cultures and antibiotic susceptibility testing identified infections no longer responding to conventional medicines, allowing doctors to select effective treatments instead of prescribing antibiotics blindly.
Dr Niazi urged clinicians to collect appropriate samples before administering antibiotics whenever feasible, without delaying emergency treatment, and review prescriptions after 48 to 72 hours to discontinue unnecessary drugs or switch to more targeted treatment.
Clinical pharmacist Waqas Ahmad warned that pharmaceutical innovation was failing to keep pace with bacterial resistance. Of 90 antibacterial products undergoing clinical development globally in 2025, only a handful offered promising activity against some of the most dangerous resistant bacteria.
He said newer antibiotics, including cefiderocol and aztreonam-avibactam, remained unregistered in Pakistan, while regulatory and pricing procedures contributed to delays in accessing advanced treatments.
Ahmad advocated hospital antibiotic-stewardship programmes, rapid diagnostic testing, infection prevention and restrictions on unnecessary use of last-resort antibiotics.
Pakistan has introduced its National Action Plan on Antimicrobial Resistance for 2024–2028, covering human, animal and environmental health, but effective implementation remains crucial to protecting patients against increasingly difficult-to-treat infections. who.int
